90 related articles for article (PubMed ID: 21280333)
21. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis.
Peng Z; Zhang Y; Gu W; Wang Z; Li D; Zhang F; Qiu G; Xie K
Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132
[TBL] [Abstract][Full Text] [Related]
22. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
[TBL] [Abstract][Full Text] [Related]
23. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection.
Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M
J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851
[TBL] [Abstract][Full Text] [Related]
24. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
25. [Pathogenetic role of HBV in liver cell carcinoma of Western European patients].
Herrmann G; Gregel C; Hübner K
Verh Dtsch Ges Pathol; 1995; 79():126-31. PubMed ID: 8600676
[TBL] [Abstract][Full Text] [Related]
26. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
27. Surface, core, and X genes of hepatitis B virus in hepatocellular carcinoma: an in situ hybridization study.
Jayshree RS; Sridhar H; Devi GM
Cancer; 2003 Feb; 99(1):63-7. PubMed ID: 12589648
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis B virus replication status and its response to surgery for tumor in hepatocellular carcinoma patients with positive markers of HBV].
Chen T; Ou Q; Chen J; Deng Q; Zhang F
Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):652-4. PubMed ID: 11825489
[TBL] [Abstract][Full Text] [Related]
29. [Integration of hepatitis B virus DNA in liver tissues from patients with hepatocellular carcinoma and liver cirrhosis].
Zhang PY; Wang YY; Cheng J; Lang ZW; Yang Q; Zhang JZ; Huang DZ; Yang YJ
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):389-90. PubMed ID: 15918983
[No Abstract] [Full Text] [Related]
30. [Using 3 primer pairs to detect HBV DNA in liver tissues from hepatocellular carcinomas with PCR technique].
Chen M; Lu L; Yao JL
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):188-91. PubMed ID: 7956696
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
Obika M; Shinji T; Fujioka S; Terada R; Ryuko H; Lwin AA; Shiraha H; Koide N
Intervirology; 2008; 51(1):59-68. PubMed ID: 18349544
[TBL] [Abstract][Full Text] [Related]
32. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
[TBL] [Abstract][Full Text] [Related]
33. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.
Paterlini P; Poussin K; Kew M; Franco D; Brechot C
Hepatology; 1995 Feb; 21(2):313-21. PubMed ID: 7843699
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
[TBL] [Abstract][Full Text] [Related]
35. HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers.
Comar M; Dal Molin G; D'Agaro P; Crocè SL; Tiribelli C; Campello C
J Clin Pathol; 2006 May; 59(5):526-9. PubMed ID: 16537674
[TBL] [Abstract][Full Text] [Related]
36. Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma.
Jicai Z; Zongtao Y; Jun L; Haiping L; Jianmin W; Lihua H
Mol Carcinog; 2006 Jul; 45(7):530-6. PubMed ID: 16649250
[TBL] [Abstract][Full Text] [Related]
37. [A prospective study of the relationship between serum hepatitis B virus DNA and the risk of primary liver cancer].
Chen QY; Dong BQ; Yang JY; Wei SC; Fang KX; Wang XY; Fang ZL
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):930-4. PubMed ID: 20038336
[TBL] [Abstract][Full Text] [Related]
38. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.
Wang Y; Lau SH; Sham JS; Wu MC; Wang T; Guan XY
Oncogene; 2004 Jan; 23(1):142-8. PubMed ID: 14712219
[TBL] [Abstract][Full Text] [Related]
39. Localization of hepatitis B virus DNA in hepatocellular carcinoma by polymerase chain reaction in situ hybridization.
Shin YJ; Cho SW; Hahm KB; Kim YS; Kim JH; Park KH; Lee SI
J Korean Med Sci; 1998 Aug; 13(4):377-82. PubMed ID: 9741541
[TBL] [Abstract][Full Text] [Related]
40. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]